These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 24353015

  • 21. The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation.
    Ettl T, Schwarz-Furlan S, Haubner F, Müller S, Zenk J, Gosau M, Reichert TE, Zeitler K.
    Oral Oncol; 2012 Sep; 48(9):822-30. PubMed ID: 22445095
    [Abstract] [Full Text] [Related]

  • 22. Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma.
    Li S, Kong Y, Si L, Chi Z, Cui C, Sheng X, Guo J.
    BMC Cancer; 2014 May 28; 14():376. PubMed ID: 24886512
    [Abstract] [Full Text] [Related]

  • 23. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM.
    Cancer Res; 2007 May 01; 67(9):4287-94. PubMed ID: 17483341
    [Abstract] [Full Text] [Related]

  • 24. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H, Hager T, Wohlschlaeger J, Bauer S, Katenkamp K, Katenkamp D, Baba HA.
    Hum Pathol; 2013 Oct 01; 44(10):2266-74. PubMed ID: 23871289
    [Abstract] [Full Text] [Related]

  • 25. [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma].
    Li JF, Li GD, Gu L, Liu WP, Li FY, Liao DY, Ma ZG.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Oct 01; 29(10):649-53. PubMed ID: 19176054
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ, Xia ZG, Wang AH, Wang WF, Liu ZY, Chen LY, Li JM.
    Ann Hematol; 2013 Oct 01; 92(10):1351-8. PubMed ID: 23636313
    [Abstract] [Full Text] [Related]

  • 28. Forskolin attenuates the action of insulin on the Akt-mTOR pathway in human skeletal muscle.
    Richmond SR, Touchberry CD, Gallagher PM.
    Appl Physiol Nutr Metab; 2009 Oct 01; 34(5):916-25. PubMed ID: 19935854
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.
    Petricoin EF, Espina V, Araujo RP, Midura B, Yeung C, Wan X, Eichler GS, Johann DJ, Qualman S, Tsokos M, Krishnan K, Helman LJ, Liotta LA.
    Cancer Res; 2007 Apr 01; 67(7):3431-40. PubMed ID: 17409454
    [Abstract] [Full Text] [Related]

  • 31. Synergistic effects of erlotinib and everolimus on bronchial carcinoids and large-cell neuroendocrine carcinomas with activated EGFR/AKT/mTOR pathway.
    Bago-Horvath Z, Sieghart W, Grusch M, Lackner A, Hayden H, Pirker C, Komina O, Węsierska-Gądek J, Haitel A, Filipits M, Berger W, Schmid K.
    Neuroendocrinology; 2012 Apr 01; 96(3):228-37. PubMed ID: 22378048
    [Abstract] [Full Text] [Related]

  • 32. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
    Komori Y, Yada K, Ohta M, Uchida H, Iwashita Y, Fukuzawa K, Kashima K, Yokoyama S, Inomata M, Kitano S.
    J Hepatobiliary Pancreat Sci; 2014 Apr 01; 21(4):288-95. PubMed ID: 24002888
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ.
    J Vasc Surg; 2013 Feb 01; 57(2):475-85. PubMed ID: 23265586
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Helicobacter pylori promotes eukaryotic protein translation by activating phosphatidylinositol 3 kinase/mTOR.
    Sokolova O, Vieth M, Gnad T, Bozko PM, Naumann M.
    Int J Biochem Cell Biol; 2014 Oct 01; 55():157-63. PubMed ID: 25194338
    [Abstract] [Full Text] [Related]

  • 40. Expression of therapeutic targets in Ewing sarcoma family tumors.
    Ahmed AA, Sherman AK, Pawel BR.
    Hum Pathol; 2012 Jul 01; 43(7):1077-83. PubMed ID: 22196127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.